Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2007
Published online before print April 26, 2007, doi: 10.1161/01.RES.0000268497.93085.e1
A more recent version of this article appeared on May 25, 2007
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
100/10/1476    most recent
01.RES.0000268497.93085.e1v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsai, C.-T.
Right arrow Articles by Lin, J.-L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsai, C.-T.
Right arrow Articles by Lin, J.-L.
Related Collections
Right arrow ACE/Angiotension receptors
Right arrow Arrythmias-basic studies

Submitted on July 28, 2006
Revised on April 15, 2007
Accepted on April 18, 2007

Angiotensin II Increases Expression of {alpha}1C Subunit of L-Type Calcium Channel Through a Reactive Oxygen Species and cAMP Response Element-Binding Protein-Dependent Pathway in HL-1 Myocytes

Chia-Ti Tsai ; Danny Ling Wang ; Wen-Pin Chen ; Juey-Jen Hwang ; Chia-Shan Hsieh ; Kuan-Lih Hsu ; Chuen-Den Tseng ; Ling-Ping Lai ; Yung-Zu Tseng ; Fu-Tien Chiang *; and Jiunn-Lee Lin

From the Division of Cardiology (C.-T.T., J.-J.H., C.-S.H., K.-L.H., C.-D.T., L.-P.L., Y.-Z.T., F.-T.C., J.-L.L.), Department of Internal Medicine, National Taiwan University Hospital, Taipei; Institute of Biomedical Sciences (D.L.W.), Academia Sinica, Taipei; and Institute of Pharmacology (W.-P.C., L.-P.L.) and Department of Laboratory Medicine (F.-T.C.), National Taiwan University Hospital, Taipei, Taiwan.

* To whom correspondence should be addressed. E-mail: futienc{at}ha.mc.ntu.edu.tw.

Angiotensin II (Ang II) is involved in the pathogenesis of atrial fibrillation (AF). L-type calcium channel (LCC) expression is altered in AF remodeling. We investigated whether Ang II modulates LCC current through transcriptional regulation, by using murine atrial HL-1 cells, which have a spontaneous calcium transient, and an in vivo rat model. Ang II increased LCC {alpha}1C subunit mRNA and protein levels and LCC current density, which resulted in an augmented calcium transient in atrial myocytes. An {approx}2-kb promoter region of LCC {alpha}1C subunit gene was cloned to the pGL3 luciferase vector. Ang II significantly increased promoter activity in a concentration- and time-dependent manner. Truncation and mutational analysis of the LCC {alpha}1C subunit gene promoter showed that cAMP response element (CRE) (-1853 to -1845) was an important cis element in Ang II-induced LCC {alpha}1C subunit gene expression. Transfection of dominant-negative CRE binding protein (CREB) (pCMV-CREBS133A) abolished the Ang II effect. Ang II (1 µmol/L, 2 hours) induced serine 133 phosphorylation of CREB and binding of CREB to CRE and increased LCC {alpha}1C subunit gene promoter activity through a protein kinase C/NADPH oxidase/reactive oxygen species pathway, which was blocked by the Ang II type 1 receptor blocker losartan and the antioxidant simvastatin. In the rat model, Ang II infusion increased LCC {alpha}1C subunit expression and serine 133 phosphorylation of CREB, which were attenuated by oral losartan and simvastatin. In summary, Ang II induced LCC {alpha}1C subunit expression via a protein kinase C-, reactive oxygen species-, and CREB-dependent pathway and was blocked by losartan and simvastatin.


Key words: angiotensin II • dihydropyridine receptor {alpha} 1C subunit • transcriptional regulation • signal transduction • cAMP response element-binding protein




This article has been cited by other articles:


Home page
J CARDIOVASC PHARMACOL THERHome page
B.-Y. Kang and J. L. Mehta
Rosuvastatin Attenuates Ang II--Mediated Cardiomyocyte Hypertrophy via Inhibition of LOX-1
Journal of Cardiovascular Pharmacology and Therapeutics, December 1, 2009; 14(4): 283 - 291.
[Abstract] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
C.-K. Wu, C.-D. Tseng, Y.-T. Huang, C.-S. Hsieh, W.-S. Tsai, J.-L. Lin, F.-T. Chiang, and C.-T. Tsai
Angiotensin II does not influence expression of sarcoplasmic reticulum Ca2 + ATPase in atrial myocytes
Journal of Renin-Angiotensin-Aldosterone System, September 1, 2009; 10(3): 121 - 126.
[Abstract] [PDF]


Home page
Circ. Res.Home page
E. Schroder, M. Byse, and J. Satin
L-Type Calcium Channel C Terminus Autoregulates Transcription
Circ. Res., June 19, 2009; 104(12): 1373 - 1381.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C.-T. Tsai, L.-P. Lai, J.-J. Hwang, J.-L. Lin, and F.-T. Chiang
Molecular Genetics of Atrial Fibrillation
J. Am. Coll. Cardiol., July 22, 2008; 52(4): 241 - 250.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C.-T. Tsai, L.-P. Lai, K.-T. Kuo, J.-J. Hwang, C.-S. Hsieh, K.-L. Hsu, C.-D. Tseng, Y.-Z. Tseng, F.-T. Chiang, and J.-L. Lin
Angiotensin II Activates Signal Transducer and Activators of Transcription 3 via Rac1 in Atrial Myocytes and Fibroblasts: Implication for the Therapeutic Effect of Statin in Atrial Structural Remodeling
Circulation, January 22, 2008; 117(3): 344 - 355.
[Abstract] [Full Text] [PDF]